PSA (prostate-specific antigen)
A protein produced by the prostate gland; its level in blood is used as a screening test for prostate cancer, though it has poor specificity for detecting dangerous cancers
As defined in How early cancer screening can save lives | Peter Attia & Keith Flaherty
Where it comes up · 1
Most important claims · 5 of 5Search all claims for “PSA (prostate-specific antigen)” →
- Sequencing technology has advanced sufficiently that from a single 10-milliliter blood sample—especially when collected at multiple time points to establish trends (analogous to PSA velocity)—cancer DNA can be detected across a broad array of cancer types.How early cancer screening can save lives | Peter Attia & Keith Flaherty
- Single-modality screening tests like mammography, colonoscopy, and PSA alone are not adequate by themselves due to their individual limitations (blind spots, poor sensitivity in certain tissue types, non-specificity).How early cancer screening can save lives | Peter Attia & Keith Flaherty
- PSA testing alone is nearly meaningless for cancer detection, but PSA density, PSA velocity, and additional tests like 4K score substantially improve specificity when layered together.How early cancer screening can save lives | Peter Attia & Keith Flaherty
- Prostate cancer screening using PSA (prostate-specific antigen) testing is poorly effective at detecting truly dangerous prostate cancers and is essentially equivalent to randomly assigning men to prostate biopsies.How early cancer screening can save lives | Peter Attia & Keith Flaherty
- Keith reports he has not performed a single unnecessary prostate biopsy in 10 years by using multi-parametric screening (PSA velocity, density, 4K, multiparametric MRI) rather than PSA alone, demonstrating the clinical effectiveness of layered screening approaches.How early cancer screening can save lives | Peter Attia & Keith Flaherty